Clinical trial
HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
NCT06127290 is registered in ClinicalTrials.gov with Euresist Network GEIE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
- Lead sponsor
- Euresist Network GEIE
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 1, 2021
- Completion date
- May 31, 2025
- Enrollment
- 200 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1-infection